Bladder cancer: open trials in Bulgaria

• NCT07265947

  Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

  Trial Treatment · Phase 2 · Tyra Biosciences, Inc

  University Multiprofessional Hospital For Active Treatment Plovdiv AD, Plovdiv · Alexandrovska University Hospital, Sofia · University Multiprofile Hospital For Active Treatment And Emergency Medicine N I Pirogov, Sofiya

  Registry updated 2026-11-02

• 2026-526359-75-00

  A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013

  Trial Treatment · Phase 4 · Urogen Pharma Ltd.

  Multiprofile Hospital For Active Treatment "Dr. Tota Venkova" AD, Gabrovo · Multiprofile Hospital For Active Treatment - Shumen AD, Shumen · University Multiprofile Hospital For Active Treatment And Emergency Medicine N I Pirogov, Sofiya

  Registry updated 2026-09-15

• NCT05303532

  Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab

  Trial Treatment · Phase 3 · Astrazeneca AB

  Multiprofile Hospital For Active Treatment Serdicamed EOOD, Sofia · University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD, Sofia

  Registry updated 2026-09-08

• NCT06774131

  A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  Trial Treatment · Phase 3 · UroGen Pharma Ltd.

  MHAT Haskovo AD, Haskovo · University Multiprofile Hospital for Active Treatment "Sveti Georgi", Plovdiv, Plovdiv · Multiprofile Hospital for Active Treatment - Shumen, Department of Urology, Shumen · University Multiprofile Hospital for Active Treatment and Emergency Medicine "N.I. Pirogov," Sofia, Clinic of Urology, Sofia

  Registry updated 2026-09-03

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error